Basal-like and triple-negative breast cancers. Searching for positives among many negatives

Prasanna Alluri, Lisa A. Newman

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

Triple-negative breast cancers (TNBC) are defined by their failure to express the estrogen receptor, progesterone receptor, and HER2/. neu protein markers. This basic feature is clinically relevant because it indicates that these cancers cannot be managed with endocrine or anti-HER2 systemic therapies. Furthermore, most TNBC cases are also characterized as being of the genetically defined basal subtype, which is an inherently and biologically more aggressive pattern of disease. The two terms, however, are not synonymous, and some TNBC cases are prognostically more favorable. TNBC differs from non-TNBC in risk-factor profile, pattern, and rate of metastatic spread.

Original languageEnglish (US)
Pages (from-to)567-577
Number of pages11
JournalSurgical Oncology Clinics of North America
Volume23
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Triple Negative Breast Neoplasms
Progesterone Receptors
Estrogen Receptors
Breast Neoplasms
Neoplasms
Proteins

Keywords

  • Basal breast cancer
  • Breast cancer subtypes
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Basal-like and triple-negative breast cancers. Searching for positives among many negatives. / Alluri, Prasanna; Newman, Lisa A.

In: Surgical Oncology Clinics of North America, Vol. 23, No. 3, 01.01.2014, p. 567-577.

Research output: Contribution to journalReview article

@article{96aac180fdd8453592ac55283afaf1c4,
title = "Basal-like and triple-negative breast cancers. Searching for positives among many negatives",
abstract = "Triple-negative breast cancers (TNBC) are defined by their failure to express the estrogen receptor, progesterone receptor, and HER2/. neu protein markers. This basic feature is clinically relevant because it indicates that these cancers cannot be managed with endocrine or anti-HER2 systemic therapies. Furthermore, most TNBC cases are also characterized as being of the genetically defined basal subtype, which is an inherently and biologically more aggressive pattern of disease. The two terms, however, are not synonymous, and some TNBC cases are prognostically more favorable. TNBC differs from non-TNBC in risk-factor profile, pattern, and rate of metastatic spread.",
keywords = "Basal breast cancer, Breast cancer subtypes, Triple-negative breast cancer",
author = "Prasanna Alluri and Newman, {Lisa A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.soc.2014.03.003",
language = "English (US)",
volume = "23",
pages = "567--577",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Basal-like and triple-negative breast cancers. Searching for positives among many negatives

AU - Alluri, Prasanna

AU - Newman, Lisa A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Triple-negative breast cancers (TNBC) are defined by their failure to express the estrogen receptor, progesterone receptor, and HER2/. neu protein markers. This basic feature is clinically relevant because it indicates that these cancers cannot be managed with endocrine or anti-HER2 systemic therapies. Furthermore, most TNBC cases are also characterized as being of the genetically defined basal subtype, which is an inherently and biologically more aggressive pattern of disease. The two terms, however, are not synonymous, and some TNBC cases are prognostically more favorable. TNBC differs from non-TNBC in risk-factor profile, pattern, and rate of metastatic spread.

AB - Triple-negative breast cancers (TNBC) are defined by their failure to express the estrogen receptor, progesterone receptor, and HER2/. neu protein markers. This basic feature is clinically relevant because it indicates that these cancers cannot be managed with endocrine or anti-HER2 systemic therapies. Furthermore, most TNBC cases are also characterized as being of the genetically defined basal subtype, which is an inherently and biologically more aggressive pattern of disease. The two terms, however, are not synonymous, and some TNBC cases are prognostically more favorable. TNBC differs from non-TNBC in risk-factor profile, pattern, and rate of metastatic spread.

KW - Basal breast cancer

KW - Breast cancer subtypes

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84901586809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901586809&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2014.03.003

DO - 10.1016/j.soc.2014.03.003

M3 - Review article

C2 - 24882351

AN - SCOPUS:84901586809

VL - 23

SP - 567

EP - 577

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 3

ER -